Viking Therapeutics, Inc. (VKTX)
NCM – Real Time Price. Currency in USD
34.18
+0.38 (1.12%)
Market open: Aug 12, 2026, 10:12 AM EDT
33.86
+0.06 (0.18%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
34.18
+0.38 (1.12%)
Market open: Aug 12, 2026, 10:12 AM EDT
33.86
+0.06 (0.18%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $125.8M significantly exceed its total debt $4.1M, ensuring strong financial flexibility
Total current assets $517.6M exceed Total current liabilities $109.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$125.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.72 | 6.05 | 10 | |
| Quick ratio | 4.72 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -291K | -292K | -346K | -431K | -450K |
| Operating Income | -70M | -101M | -151M | -393M | -560M |
| Net Income | -69M | -86M | -110M | -360M | -535M |
| EBITDA | -70M | -101M | -151M | -393M | -560M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -31.69 | 1.0 |
| Next quarter | N/A | 21.5 | 5.5 |
| Current year | N/A | -44.1 | 1.0 |
| Next year | N/A | 3.77 | 2.5 |
| Weighted average score | 2.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 19.14 | 19.71 | -9.81 | 7.3 |
| Y/Y | 999 | -95.26 | -89.65 | -165.97 | 3.3 |
| 3y average | 999 | -93.25 | -75.96 | -96.21 | 3.3 |
| 5y average | 999 | -68.83 | -57.22 | -81.76 | 3.3 |
| Weighted average score | 4.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |